Steward Health Care is the first hospital system in Arizona to use Zeto EEG technology – the first true dry electrode EEG system cleared for clinical use by the FDA. Both Mountain Vista Medical Center and Tempe St. Lukes now offer Zeto EEG headsets for routine EEG, one of the main diagnostic tests for epilepsy and other brain disorders. A zero-prep, easy to wear headset with no-residue electrodes, the Zeto EEG technology is backed by a cloud platform that offers live viewing, video, auxiliary inputs, and tools for analysis. The headset and software platform allows Steward’s trained healthcare professionals to administer routine and urgent EEGs at a moment's notice, enhancing our commitment to providing the highest-quality care and most up-to-date technology for our patients.
“We are excited to be the first hospital system in Arizona to be able to provide the newest technology in bedside EEG recording for patients,” said Damon Brown, Arizona President of Steward Health Care. “The Zeto system offers the best patient experience for EEG tests with no more application of electrodes to the skin with gel or tethering of the patient to a box with wires.”
Traditional EEG systems are often inconvenient for patients due to the need to measure the patient's head, mark the location of the electrodes, resurface the skin, apply a conductive paste, and glue the electrodes. The Zeto EEG headset improves patient comfort by reducing preparation time. Dry electrodes are cleaner, more convenient, quicker to install and quicker to remove.
"Our company is delighted that Zeto EEG headsets are available to patients in Arizona at Mountain Vista Medical Center and Tempe St. Lukes, Steward Health Care hospitals,” said Florian Strelzyk, Chief Sales Officer of Zeto, Inc. “The increasing shortage of EEG technologists is making EEG monitoring unavailable in several hospitals and clinics around the US. The Zeto headset and software platform offers quick, comfortable, medical-grade EEG monitoring. With no paste needed, setup time under 5 minutes and minimal clean-up, a trained healthcare professional can now administer this important test at a moment's notice. The data is available live with video via a HIPAA compliant cloud backed by our rich and intuitive report generation feature. We are committed to serving Steward Health Care hospitals, and help their patients, physicians and staff realize the benefits of using Zeto EEG for the long term.”
About Steward Health Care System
Nearly a decade ago, Steward Health Care System emerged as a different kind of health care company designed to usher in a new era of wellness. One that provides our patients better, more proactive care at a sustainable cost, our providers unrivaled coordination of care, and our communities greater prosperity and stability. As the country’s largest physician-led, tax paying, integrated health care system, our doctors can be certain that we share their interests and those of their patients. Together we are on a mission to revolutionize the way health care is delivered - creating healthier lives, thriving communities and a better world.
Steward is among the nation’s largest and most successful accountable care organizations (ACO), with more than 5,500 providers and 43,000 health care professionals who care for 12.3 million patients a year through a closely integrated network of hospitals, multispecialty medical groups, urgent care centers, skilled nursing facilities and behavioral health centers. Based in Dallas, Steward currently operates 39 hospitals across Arizona, Arkansas, Florida, Louisiana, Massachusetts, Ohio, Pennsylvania, Texas and Utah.
About Zeto, Inc.
Zeto, Inc. is an award-winning privately held medical technology company located in Santa Clara, CA focused on transforming the way electroencephalography (EEG) is performed at hospitals and clinics. Zeto's revolutionary FDA-cleared EEG headset and cloud platform bring the traditional EEG procedure to the 21st century. The company plans to leverage its hardware and software technology to improve noninvasive monitoring of the brain's electrical activity and achieve better outcomes for neurological conditions such as epilepsy, sleep disorders, autism, stroke and concussion.
Director of Marketing and Communications
P:4 80.358.6152 | C: 316.210.4868
There is no offer to sell, no solicitation of an offer to buy, and no recommendation of any security or any other product or service in this article. Moreover, nothing contained in this PR should be construed as a recommendation to buy, sell, or hold any investment or security, or to engage in any investment strategy or transaction. It is your responsibility to determine whether any investment, investment strategy, security, or related transaction is appropriate for you based on your investment objectives, financial circumstances, and risk tolerance. Consult your business advisor, attorney, or tax advisor regarding your specific business, legal, or tax situation.
Release ID: 102724